Related Experiment Video
Updated: Jun 5, 2026

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
Abstract:
Tranexamic acid, an oral antifibrinolytic, is due to become available soon for purchase from pharmacies without prescription for the self-management of heavy menstrual bleeding. It is the first over-the-counter (OTC) medicine licensed specifically for this condition.1 The Medicines and Healthcare products Regulatory Agency (MHRA) views such availability of tranexamic acid (to be sold as Cyklo-F) as "an important step for women, helping improve their quality of life and providing them with the greater convenience of better access to medicines".1 Here we review the efficacy and safety of tranexamic acid and discuss whether its OTC availability is a helpful development.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
